Add to Basket Bulk discount
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) antibody

Antigen

phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1)

Synonyms CBP, RSTS, KAT3A, PAG, FLJ37858, MGC138364, Cbp, Pag, F730007C19Rik, MGC80192
Clonality Monoclonal (PAG-C1)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human, Mouse (Murine), Rat (Rattus), Cow (Bovine)

Conjugate
Alternatives Un-conjugated
Application
Alternatives Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
3 references available
Catalog no. ABIN94270
Quantity 0.1 mg  (1 mg/ml)
Price 363.00 $   Plus shipping costs $45.00
Bulk discount
Shipping to
Availability Will be delivered in 4 to 5 Business Days

Additional Information

Alternative name PAG / Cbp
Immunogen C-terminal peptide (last 15 amino acids) of human Csk binding protein coupled to KLH.
Isotype IgG2b
Clone PAG-C1
Description PAG (phosphoprotein associated with GEMs), also known as Cbp (Csk-binding protein), is aubiquitously expressed 46 kDa transmembrane adaptor protein present in membrane rafts(glycosphingolipid-enriched microdomains), which however migrates on SDS PAGE gelsanomalously as an 80 kDa molecule. Following tyrosine phosphorylation by Src familykinases, PAG binds and thereby activates the protein tyrosine kinase Csk, the majornegative regulator of the Src family kinases. Signaling via the B-cell receptor in B cells orhigh affinity IgE receptor (FcepsilonRI) in mast cells leads to PAG increased tyrosinephosphorylation and Csk binding, while T cell receptor signaling causes PAGdephosphorylation, loss of Csk binding and increased activation of the protein tyrosinekinase Lck.
Specificity The antibody PAG-C1 recognizes an epitope located in the C-terminal domain ofCsk-binding protein (Cbp / PAG), a 46 kDa ubiquitously expressed transmembrane adaptorprotein present in membrane rafts (glycosphingolipid-enriched microdomains), whichhowever migrates on SDS PAGE gels anomalously as an 80 kDa molecule.

Application Details

Application Notes Immunoprecipitation - Positive control: RAJI human Burkitt lymphoma cell line. Immunohistochemistry (paraffin sections) - Positive tissue: Appendix (germinal center of lymphatic follicle. Application note: heat-mediated antigen retrieval in citrate buffer pH 6. 1
Concentration 1 mg/ml
Purity > 95% (by SDS-PAGE)
Purification Purified from ascites by protein-A affinity chromatography.
Buffer Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
Storage Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles.
Restrictions For Research Use only

Publications

Baumgartner, Angelisová, Setterblad et al.: "Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes." in: Blood, Vol. 101, Issue 5, pp. 1874-81, 2003 (PubMed).

Davidson, Bakinowski, Thomas et al.: "Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor." in: Molecular and cellular biology, Vol. 23, Issue 6, pp. 2017-28, 2003 (PubMed).

Vang, Abrahamsen, Myklebust et al.: "Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling." in: The Journal of biological chemistry, Vol. 278, Issue 20, pp. 17597-600, 2003 (PubMed).

Alternatives

Alternatives for antigen "phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1)", type "Antibodies"
Hosts Mouse (25), Rabbit (10)
Reactivities Human (32), Mouse (Murine) (3), Cow (Bovine) (2), Rat (Rattus) (1)
Applications Western Blotting (WB) (24), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (19), Flow Cytometry (FACS) (14), Immunoprecipitation (IP) (13), ELISA (2)
Conjugates Alexa Fluor 488 (2), Alexa Fluor 700 (2), DyLight 649 (2), DY647 (1), Dyomics 647 (1)
Epitopes AA 97-432 (19), C-Term (6), N-Term (1)